Publikationen 2009

  1. Balgobind BV, Raimondi SC, Harbott J, Zimmermann M, Alonzo TA, Auvrignon A, Beverloo HB, Chang M, Creutzig U, Dworzak MN, Forestier E, Gibson B, Hasle H, Harrison CJ, Heerema NA, Kaspers GJ, Leszl A, Litvinko N, Nigro LL, Morimoto A, Perot C, Pieters R, Reinhardt D, Rubnitz JE, Smith FO, Stary J, Stasevich I, Strehl S, Taga T, Tomizawa D, Webb D, Zemanova Z, Zwaan CM, van den Heuvel-Eibrink MM: Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study. Blood 2009;114:2489-2496. www.ncbi.nlm.nih.gov/pubmed/19528532
  2. Creutzig U, Zimmermann M, Kaspers G, Reinhardt D: Postremission Management of Acute Myelogenous Leukemia in Children and Adolescents with and without Hematopoietic Stem Cell Transplantation in European and U.S.Study Groups; in Govindan R, (ed): American Society of Clinical Oncology - Educational Book (45th Annual Meeting, Spring 2009). Alexandria, Curzio,J., 2009, pp 609-615.
  3. Hollink IH, Zwaan CM, Zimmermann M, Arentsen-Peters TC, Pieters R, Cloos J, Kaspers GJ, de Graaf SS, Harbott J, Creutzig U, Reinhardt D, van den Heuvel-Eibrink MM, Thiede C: Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML. Leukemia 2009;23:262-270. www.ncbi.nlm.nih.gov/pubmed/19020547
  4. Hollink IH, van den Heuvel-Eibrink MM, Zimmermann M, Balgobind BV, Arentsen-Peters ST, Alders M, Willasch A, Kaspers GJ, Trka J, Baruchel A, de Graaf SS, Creutzig U, Pieters R, Reinhardt D, Zwaan CM: Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia. Blood 2009;113:5951-5960. www.ncbi.nlm.nih.gov/pubmed/19171881
  5. Lehrnbecher T, Creutzig U: Myeloid growth factors as anti-infective measures in children with leukemia and lymphoma. Expert Rev Hematol 2009;2:159-172. www.ncbi.nlm.nih.gov/pubmed/21083449
  6. Lehrnbecher T, Ethier MC, Zaoutis T, Creutzig U, Gamis A, Reinhardt D, Aplenc R, Sung L: International variations in infection supportive care practices for paediatric patients with acute myeloid leukaemia. Br J Haematol 2009;147:125-128. www.ncbi.nlm.nih.gov/pubmed/19663826
  7. Reimann V, Creutzig U, Kogler G: Stem cells derived from cord blood in transplantation and regenerative medicine. Dtsch Arztebl Int 2009;106:831-836. www.ncbi.nlm.nih.gov/pubmed/20049094
  8. Scharn N, Ballmaier M, Reinhardt K, Ehlers S, Zimmermann M, Welte K, Reinhardt D, Germeshausen M: CSF3R mutations in paediatric acute myeloid leukaemia. Br J Haematol 2009;144:140-142. www.ncbi.nlm.nih.gov/pubmed/19016735
  9. Tallen G, Dworzak M, Gadner H, Masera G, Haupt R, Eggert A, Schrappe M, Biondi A, Vassal G, Creutzig U: More and better cure for an orphan: priorities for future paediatric cancer research in Europe – Meeting report of the EC-funded science-communication project DIRECT "Overcoming Cancer with Research". memo - magazine of european medical oncology 2009;4:246-254.
  10. Tallen G, Dworzak M, Gadner H, Masera G, Haupt R, Eggert A, Schrappe M, Biondi A, Vassal G, Creutzig U: Imperative of continual support by the European Community for future advances in paediatric oncology in Europe: meeting report of the EC-funded science-communication project DIRECT "Overcoming Cancer with Research". memo - magazine of european medical oncology 2009;4:234-245.
  11. Willasch AM, Gruhn B, Coliva T, Kalinova M, Schneider G, Kreyenberg H, Steinbach D, Weber G, Hollink IH, Zwaan CM, Biondi A, van der Velden V, Reinhardt D, Cazzaniga G, Bader P, Trka J: Standardization of WT1 mRNA quantitation for minimal residual disease monitoring in childhood AML and implications of WT1 gene mutations: a European multicenter study. Leukemia 2009;23:1472-1479. www.ncbi.nlm.nih.gov/pubmed/19322206
Suchen
Benutzeranmeldung